Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tilmann J Geldbach

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Journal of Medicinal Chemistry|June 10, 2005
In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexesClaudine Scolaro, Alberta Bergamo, Laura Brescacin, et al.
Journal of Medicinal Chemistry|October 7, 2008
Emerging protein targets for anticancer metallodrugs: inhibition of thioredoxin reductase and cathepsin B by antitumor ruthenium(II)-arene compoundsAngela Casini, Chiara Gabbiani, Francesca Sorrentino, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Journal of Medicinal Chemistry|June 10, 2005
In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexesClaudine Scolaro, Alberta Bergamo, Laura Brescacin, et al.
Journal of Medicinal Chemistry|October 7, 2008
Emerging protein targets for anticancer metallodrugs: inhibition of thioredoxin reductase and cathepsin B by antitumor ruthenium(II)-arene compoundsAngela Casini, Chiara Gabbiani, Francesca Sorrentino, et al.
Pageof 2